Copies of letters that Senator Grassley received from drug makers in response to his request for them to follow Eli Lilly’s lead and disclose financial contributions to continuing medical education are posted with this statement at http://finance.senate.gov. Right now,Senator Grassley does not plan to pursue disclosure legislation separate from the Physician Payment Sunshine Act. He will carefully monitor implementation of the disclosure plans described in these letters and consider additional initiatives, including legislation, if transparency is not achieved.Click here to read this press release and the response letters from these companies.
Saturday, April 12, 2008
Senator Grassley press release
From the Senator's 4-11-08 press release: